Dexamethasone inhibits antitumor potential of activated macrophages by a receptor mediated action
- 1 April 1986
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 136 (1) , 130-136
- https://doi.org/10.1016/0006-291x(86)90886-7
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- RU 38486: A potent antiglucocorticoid in vitro and in vivoThe Journal of Steroid Biochemistry and Molecular Biology, 1985
- Products of the lipoxygenase pathway in human natural killer cell cytotoxicityCellular Immunology, 1985
- Iron depletion: Possible cause of tumor cell cytotoxicity induced by activated macrophagesBiochemical and Biophysical Research Communications, 1984
- RU 38486: Potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activationJournal of Steroid Biochemistry, 1984
- Differentiation of a histiocytic lymphoma cell line by lipomodulin, a phospholipase inhibitory proteinBiochemical and Biophysical Research Communications, 1983
- Dexamethasone-induced inhibition of prostaglandin production does not result from a direct action on phospholipase activities but is mediated through a steroid-inducible factorBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1982
- Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity.The Journal of Experimental Medicine, 1979
- Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions.The Journal of Experimental Medicine, 1978
- Activated macrophages kill tumour cells by releasing arginaseNature, 1978
- Macrophage plasminogen activator: Modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotidesCell, 1976